1. Home
  2. NUWE vs OAKUU Comparison

NUWE vs OAKUU Comparison

Compare NUWE & OAKUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • OAKUU
  • Stock Information
  • Founded
  • NUWE 1999
  • OAKUU N/A
  • Country
  • NUWE United States
  • OAKUU
  • Employees
  • NUWE N/A
  • OAKUU N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • OAKUU
  • Sector
  • NUWE Health Care
  • OAKUU
  • Exchange
  • NUWE Nasdaq
  • OAKUU NYSE
  • Market Cap
  • NUWE 3.9M
  • OAKUU N/A
  • IPO Year
  • NUWE N/A
  • OAKUU N/A
  • Fundamental
  • Price
  • NUWE $1.00
  • OAKUU $11.51
  • Analyst Decision
  • NUWE Strong Buy
  • OAKUU
  • Analyst Count
  • NUWE 1
  • OAKUU 0
  • Target Price
  • NUWE $17.00
  • OAKUU N/A
  • AVG Volume (30 Days)
  • NUWE 70.5K
  • OAKUU N/A
  • Earning Date
  • NUWE 05-13-2025
  • OAKUU N/A
  • Dividend Yield
  • NUWE N/A
  • OAKUU N/A
  • EPS Growth
  • NUWE N/A
  • OAKUU N/A
  • EPS
  • NUWE N/A
  • OAKUU N/A
  • Revenue
  • NUWE $8,740,000.00
  • OAKUU N/A
  • Revenue This Year
  • NUWE $22.96
  • OAKUU N/A
  • Revenue Next Year
  • NUWE $29.97
  • OAKUU N/A
  • P/E Ratio
  • NUWE N/A
  • OAKUU N/A
  • Revenue Growth
  • NUWE N/A
  • OAKUU N/A
  • 52 Week Low
  • NUWE $0.75
  • OAKUU N/A
  • 52 Week High
  • NUWE $12.60
  • OAKUU N/A
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 52.93
  • OAKUU 46.43
  • Support Level
  • NUWE $0.87
  • OAKUU $11.37
  • Resistance Level
  • NUWE $1.06
  • OAKUU $11.90
  • Average True Range (ATR)
  • NUWE 0.09
  • OAKUU 0.00
  • MACD
  • NUWE 0.02
  • OAKUU 0.00
  • Stochastic Oscillator
  • NUWE 79.31
  • OAKUU 0.00

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: